White blood cells in pregnancy: reference intervals for before and after delivery - eBioMedicine
The Neutrophil to Lymphocyte and Lymphocyte to Monocyte Ratios as New | CMAR
Neutrophil-to-lymphocyte ratio predicts critical illness patients with 2019 coronavirus disease in the early stage | Journal of Translational Medicine | Full Text
Frontiers | Neutrophils and COVID-19: Active Participants and Rational Therapeutic Targets
Granulocytosis: What Is It, Common Causes, Treatments and More | Osmosis
White Blood Cell Counts as Risk Markers of Developing Metabolic Syndrome and Its Components in the Predimed Study | PLOS ONE
Can the Neutrophil to Lymphocyte Ratio Be Used to Determine Gastric Cancer Treatment Outcomes? A Systematic Review and Meta-Analysis
Types of White Blood Cells: What the Numbers May Mean | Roswell Park Comprehensive Cancer Center - Buffalo, NY
IJMS | Free Full-Text | Granulocytes and Cells of Granulocyte Origin—The Relevant Players in Colorectal Cancer
Frontiers | Usefulness of the Neutrophil-to-Lymphocyte Ratio as a Predictor of Pneumonia and Urinary Tract Infection Within the First Week After Acute Ischemic Stroke
High neutrophil to lymphocyte ratio as a prognostic marker in COVID-19 patients - Clinical Nutrition ESPEN
PulmCrit: Neutrophil-Lymphocyte Ratio (NLR): Free upgrade to your WBC
Predicting the risk of pulmonary tuberculosis based on the neutrophil-to- lymphocyte ratio at TB screening in HIV-infected individuals | BMC Infectious Diseases | Full Text
White Blood Cells: Types, Function & Normal Ranges
Absolute Neutrophil Count (ANC) and Neutropenia - Together by St. Jude™
Could a simple biomarker as neutrophil-to-lymphocyte ratio reflect complex processes orchestrated by neutrophils? - ScienceDirect
PulmCrit: Neutrophil-Lymphocyte Ratio (NLR): Free upgrade to your WBC
High neutrophil/lymphocyte ratio and low lymphocyte percentage are independent risk factors for new-onset CKD - ScienceDirect
Complete Blood Count in Primary Care - bpacnz
Higher neutrophil-to-lymphocyte ratio (NLR) increases the risk of suboptimal platelet inhibition and major cardiovascular ischemic events among ACS patients receiving dual antiplatelet therapy with ticagrelor - ScienceDirect
Complete Blood Count in Primary Care - bpacnz
